BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Gastric cancer

1. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. SH3GL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. FAT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. BCL7A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. HNRNPA2B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. MYH9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. PTPRT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. ARHGEF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. FOXO4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. HSP90AB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. LRP1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. MLF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. RSPO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. SEPT5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. SPOP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. ABI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. AFF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. HOXC11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. PRRX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. PTPRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. SLC45A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. TRD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. ARHGAP26
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. CNTRL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. DCTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. ETNK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. FANCE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. HOXD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. IKBKB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. KDM5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. MSI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. MYO5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. NACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. NFIB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. NFKBIE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. PRDM16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. PREX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. RABEP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. SMARCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. STRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. TTL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. WHSC1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. WWTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. ZRSR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. CAD-ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. SET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. ACKR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. ACSL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. ACSL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. ATIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. ATP2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. BCL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. BCL9L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. BCORL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. BRD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. C12orf9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. C15orf65
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. C2orf44
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. CAMTA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. CBLB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. CBLC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. CCNB1IP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. CEP89
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. CHCHD7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. CHD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. CHIC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. CLP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. CLTCL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. CNOT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. COX6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. CREB3L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. CRTC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. DDX10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. DNM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. ECT2L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. ELK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. EPS15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. ERC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. FAM131B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. FAM46C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. FBXO11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. FCRL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. FNBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. FSTL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. GAS7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. GMPS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. GOLGA5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. GPHN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. H3F3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. HIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. HIST1H4I
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. HMGN2P46
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. HOOK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. HOXC13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. IL21R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. KAT6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. KCNJ5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. KDM5C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. KDSR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. KIAA1598
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. KTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. LHFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. LSM14A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. LZTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. MAFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. MAP3K13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. MDS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. MLLT11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. MLLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. MLLT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. MN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. MTCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. OMD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. P2RY8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. PAFAH1B2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. PCM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. PDE4DIP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. PRKACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. PSIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. PTPRK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. PWWP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. RANBP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. RAP1GDS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. RBM10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. RMI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. RNF213
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. RNF217-AS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. RPL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. RPN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. RSPO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. RUNDC2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. SDC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. SMARCE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. SRGAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. SS18L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. TAL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. TCEA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. TCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. TFEB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. TFPT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. THRAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. TPM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. TRAF7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. TRIM33
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. TRIP11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. USP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. VTI1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. ZCCHC8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. ZFHX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. ZNF278
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. ZNF384
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. ZNF521
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. Cytokeratin fragment 21-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. IHC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. MAP-Tau mRNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. MK167
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. Nuclear matrix protein 22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. PAM50
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]